Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins.
Tóth
G G
GG
Jonkman
M F
MF
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003875:Drug Eruptions / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous; D008875:Middle Aged; D010392:Pemphigus / Q000139:chemically induced* / Q000628:therapy*; D010396:Penicillamine / Q000009:adverse effects*
D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous; D010396:Penicillamine